Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 4c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• United Airlines flies first Starlink-equipped widebody on transatlantic route
• Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters